Nephros, Inc. (NEPH) is a Medical instruments supplies company in the Healthcare sector, listed on Nasdaq.
This page provides the complete earnings calendar, dividend schedule, and financial data for Nephros, Inc. in 2026. The next earnings report is expected on November 5, 2026.
Nephros, Inc. beat consensus estimates in its latest quarter, with EPS of $0.01 versus an estimate of $0.0033 and revenue of $5.0 million exceeding estimates by 0.1%. In the prior quarter EPS met expectations while revenue came in ahead of estimates by 3.9%.
Dividend calendar
No dividend history available.
EPS (Earnings Per Share)
Revenue
Company profile
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
